Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Time to publication of oncology trials and why some trials are never published.

Chapman PB, Liu NJ, Zhou Q, Iasonos A, Hanley S, Bosl GJ, Spriggs DR.

PLoS One. 2017 Sep 21;12(9):e0184025. doi: 10.1371/journal.pone.0184025. eCollection 2017.

2.

Air-Liquid Interface Cell Exposures to Nanoparticle Aerosols.

Lewinski NA, Liu NJ, Asimakopoulou A, Papaioannou E, Konstandopoulos A, Riediker M.

Methods Mol Biol. 2017;1570:301-313. doi: 10.1007/978-1-4939-6840-4_21.

PMID:
28238146
3.

Methodological considerations when conducting in vitro, air-liquid interface exposures to engineered nanoparticle aerosols.

Secondo LE, Liu NJ, Lewinski NA.

Crit Rev Toxicol. 2017 Mar;47(3):225-262. doi: 10.1080/10408444.2016.1223015. Epub 2016 Sep 20.

PMID:
27648750
4.

Phospholipase A2 as a point of care alternative to serum amylase and pancreatic lipase.

Liu NJ, Chapman R, Lin Y, Bentham A, Tyreman M, Philips N, Khan SA, Stevens MM.

Nanoscale. 2016 Jun 9;8(23):11834-9. doi: 10.1039/c6nr03376h.

5.

Point of care testing of phospholipase A2 group IIA for serological diagnosis of rheumatoid arthritis.

Liu NJ, Chapman R, Lin Y, Mmesi J, Bentham A, Tyreman M, Abraham S, Stevens MM.

Nanoscale. 2016 Feb 28;8(8):4482-5. doi: 10.1039/c5nr08423g.

6.

A Novel Approach to Improving Fat Delivery in Neonatal Enteral Feeding.

Jarjour J, Juarez AM, Kocak DK, Liu NJ, Tabata MM, Hawthorne KM, Ramos RF, Abrams SA.

Nutrients. 2015 Jun 23;7(6):5051-64. doi: 10.3390/nu7065051.

Supplemental Content

Loading ...
Support Center